Literature DB >> 25063709

Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse.

Seán T Anderson1, Seán Commins1, Paul N Moynagh2, Andrew N Coogan3.   

Abstract

Post-septic encephalopathy is a poorly understood condition in survivors of sepsis that is characterised by cognitive and affective impairments. In this study we have sought to better understand this condition by undertaking a comprehensive behavioural and cognitive assessment of mice who had previously survived sepsis. Mice were treated with lipopolysaccharide (LPS; 5mg/kg) and one month after this assessed on a battery of tests. Post-septic animals were found to display significantly more immobility in the tail suspension test and show a significantly decreased sucrose preference. Acute fluoxetine treatment reversed the increase in immobility in the tail suspension test in post-septic animals. Post-septic animals also showed less overall exploratory behaviour in the novel object recognition task and also showed increased anxiety-like behaviour in the elevated plus maze. Post-septic mice did not show signs of cognitive impairment, as assessed in the Morris watermaze, the 8-arm radial maze or on preference for the novel object in the novel object recognition task. Immunohistochemical analysis revealed significant upregulation of the microglial marker CD-11b, F4/80 and IBA-1 in the hippocampus of post-septic animals, as well as significant downregulation of the plasticity-related immediate early gene products ARC and EGR1. We also observed a decrease in neural stem cell proliferation in the dentate gyrus of post-septic animals as judged by BrdU incorporation. Co-treatment with the NF-κB pathway inhibitor PDTC attenuated the long-lasting effects of LPS on most of the affected parameters, but not on neural stem cell proliferation. These results show that LPS-induced sepsis in the mouse is followed by long-lasting increases in depressive- and anxiety-like behaviours, as well as by changes in neuroinflammatory- and neural plasticity-associated factors, and that attenuation of the severity of sepsis by PDTC attenuates many of these effects.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behaviour; Cognition; Depression; Hippocampus; LPS; Neuroinflammation; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25063709     DOI: 10.1016/j.bbi.2014.07.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  57 in total

1.  Sepsis survivor mice exhibit a behavioral endocrine syndrome with ventral hippocampal dysfunction.

Authors:  Joanna L Spencer-Segal; Benjamin H Singer; Klaudia Laborc; Khyati Somayaji; Stanley J Watson; Theodore J Standiford; Huda Akil
Journal:  Psychoneuroendocrinology       Date:  2020-04-13       Impact factor: 4.905

Review 2.  The intensive care delirium research agenda: a multinational, interprofessional perspective.

Authors:  Pratik P Pandharipande; E Wesley Ely; Rakesh C Arora; Michele C Balas; Malaz A Boustani; Gabriel Heras La Calle; Colm Cunningham; John W Devlin; Julius Elefante; Jin H Han; Alasdair M MacLullich; José R Maldonado; Alessandro Morandi; Dale M Needham; Valerie J Page; Louise Rose; Jorge I F Salluh; Tarek Sharshar; Yahya Shehabi; Yoanna Skrobik; Arjen J C Slooter; Heidi A B Smith
Journal:  Intensive Care Med       Date:  2017-06-13       Impact factor: 17.440

3.  NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide.

Authors:  Wei Zhu; Feng-Sheng Cao; Jun Feng; Hua-Weng Chen; Jie-Ru Wan; Qing Lu; Jian Wang
Journal:  Neuroscience       Date:  2016-12-05       Impact factor: 3.590

4.  Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis.

Authors:  Divine C Nwafor; Sreeparna Chakraborty; Allison L Brichacek; Sujung Jun; Catheryne A Gambill; Wei Wang; Elizabeth B Engler-Chiurazzi; Duaa Dakhlallah; Anthony B Pinkerton; José Luis Millán; Stanley A Benkovic; Candice M Brown
Journal:  Brain Behav Immun       Date:  2019-11-25       Impact factor: 7.217

5.  Protection of baicalin against lipopolysaccharide induced liver and kidney injuries based on 1H NMR metabolomic profiling.

Authors:  Shanting Liao; Pei Li; Junsong Wang; Qian Zhang; Dingqiao Xu; Minghua Yang; Lingyi Kong
Journal:  Toxicol Res (Camb)       Date:  2016-05-24       Impact factor: 3.524

Review 6.  The impact of inflammation on respiratory plasticity.

Authors:  Austin D Hocker; Jennifer A Stokes; Frank L Powell; Adrianne G Huxtable
Journal:  Exp Neurol       Date:  2016-07-27       Impact factor: 5.330

7.  Lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα) blunt the response of Neuropeptide Y/Agouti-related peptide (NPY/AgRP) glucose inhibited (GI) neurons to decreased glucose.

Authors:  Lihong Hao; Zhenyu Sheng; Joseph Potian; Adam Deak; Christine Rohowsky-Kochan; Vanessa H Routh
Journal:  Brain Res       Date:  2016-07-26       Impact factor: 3.252

8.  Low molecular weight heparin prevents lipopolysaccharide induced-hippocampus-dependent cognitive impairments in mice.

Authors:  Renqi Li; Jianhua Tong; Yuanhui Tan; Sihai Zhu; Jianjun Yang; Muhuo Ji
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

9.  Neonatal Lipopolysaccharide Infection Causes Demyelination and Behavioral Deficits in Adult and Senile Rat Brain.

Authors:  Kavita Singh; Nisha Patro; M Pradeepa; Ishan Patro
Journal:  Ann Neurosci       Date:  2017-07-24

10.  Systemic Lipopolysaccharide Administration-Induced Cognitive Impairments are Reversed by Erythropoietin Treatment in Mice.

Authors:  Rong Gao; Yuan-hui Tang; Jian-hua Tong; Jian-Jun Yang; Mu-huo Ji; Si-hai Zhu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.